COVID-19: The Lancet published an Argentine study on the importance of heterologous vaccination and third doses
The research evaluated efficacy in people over 60 years of age. “Against Ómicron, it is essential that adults apply the booster dose at the right time,” Dr. Andrea Gamarnik, the research leader, explained to Infobae
